ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 79 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,344 | -33.2% | 48,156 | -14.3% | 0.00% | – |
| Q2 2023 | $435,879 | -18.9% | 56,170 | -40.4% | 0.00% | – |
| Q1 2023 | $537,618 | +510.9% | 94,319 | +242.3% | 0.00% | – |
| Q3 2022 | $88,000 | -68.6% | 27,557 | -55.8% | 0.00% | – |
| Q2 2022 | $280,000 | -13.0% | 62,387 | +3.5% | 0.00% | – |
| Q1 2022 | $322,000 | -50.1% | 60,306 | +37.3% | 0.00% | – |
| Q4 2021 | $645,000 | -23.7% | 43,915 | +8.6% | 0.00% | – |
| Q3 2021 | $845,000 | +41.8% | 40,421 | +19.9% | 0.00% | – |
| Q2 2021 | $596,000 | -7.6% | 33,703 | +28.1% | 0.00% | – |
| Q1 2021 | $645,000 | +7.0% | 26,320 | +47.7% | 0.00% | – |
| Q4 2020 | $603,000 | +77.9% | 17,822 | +31.6% | 0.00% | – |
| Q3 2020 | $339,000 | -2.0% | 13,544 | +32.0% | 0.00% | – |
| Q2 2020 | $346,000 | – | 10,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |